GenomeWeb: Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

NewsJan 25, 2021Kelsy Ketchum, gemoneweb

Fluxergy highlighted the need for affordable, multimodal diagnostic testing that can expand access beyond centralized laboratories and support SARS-CoV-2 and other disease targets.

The COVID-19 pandemic has shed light on the need for mass testing, particularly in areas that don't have access to centralized laboratories or trained technicians.

Click here to view entire article: Read More

Want to talk to the team behind the platform?

Tell us what you're testing for and we'll walk you through the analyzer, the cards, and the workflow — on your samples, in your setting.

Get Demo More from the newsroom